Blake, Kimberly, Hilbert, Kevin, Ipser, Jonathan, Han, Laura, Bas-Hoogendam, Janna Marie, Ahs, Fredrik, Bauer, Jochen, Beesdo-Baum, Katja, Bjorkstrand, Johannes, Blanco-Hinojo, Laura, Bohnleim, Joscha, Bulow, Robin, Cano, Marta, Cardoner, Narcis, Caseras, Xavier ![]() |
![]() |
PDF
- Submitted Pre-Print Version
Available under License Creative Commons Attribution No Derivatives. Download (261kB) |
Abstract
Introduction Specific phobia (SPH) is a prevalent anxiety disorder and may involve advanced biological aging. However, brain age research in psychiatry has primarily examined mood and psychotic disorders. This mega-analysis investigated brain aging in SPH participants within the ENIGMA-Anxiety Working Group. Methods 3D brain structural MRI scans from 17 international samples (600 SPH individuals, of whom 504 formally diagnosed and 96 questionnaire-based cases; 1,134 controls; age range: 22-75 years) were processed with FreeSurfer. Brain age was estimated from 77 subcortical and cortical regions with a publicly available ENIGMA brain age model. The brain-predicted age difference (brain-PAD) was calculated as brain age minus chronological age. Linear mixed-effect models examined group differences in brain-PAD and moderation by age. Results No significant group difference in brain-PAD manifested (βdiagnosis (SE)=0.37 years (0.43), p=0.39). A negative diagnosis-by-age interaction was identified, which was most pronounced in formally diagnosed SPH (βdiagnosis-by-age=-0.08 (0.03), pFDR=0.02). This interaction remained significant when excluding participants with anxiety comorbidities, depressive comorbidities, and medication use. Post-hoc analyses revealed a group difference for formal SPH diagnosis in younger participants (22-35 years; βdiagnosis=1.20 (0.60), p<0.05, mixed-effects d (95% confidence interval)=0.14 (0.00-0.28)), but not older participants (36-75 years; βdiagnosis=0.07 (0.65), p=0.91). Conclusions Brain aging did not relate to SPH in the full sample. However, a diagnosis-by-age interaction was observed across analyses, and was strongest in formally diagnosed SPH. Post-hoc analyses showed a subtle advanced brain aging in young adults with formally diagnosed SPH. Taken together, these findings indicate the importance of clinical severity, impairment and persistence, and may suggest a slightly earlier end to maturational processes or subtle decline of brain structure in SPH.
Item Type: | Website Content |
---|---|
Date Type: | Published Online |
Status: | Submitted |
Schools: | Schools > Medicine Research Institutes & Centres > MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) |
Publisher: | OpenRxiv |
Date of Acceptance: | 20 March 2025 |
Last Modified: | 09 Jun 2025 11:01 |
URI: | https://orca.cardiff.ac.uk/id/eprint/178224 |
Actions (repository staff only)
![]() |
Edit Item |